A glycosylated prolactin species is covalently bound to immunoglobulin in human amniotic fluid

L J Heffner1, L S Gramates, R W Yuan

  • 1Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA.

Insights

Glycosylated prolactin in amniotic fluid is covalently bound to another protein. Further analysis shows this protein is immunoglobulin, linked via disulfide bonds, impacting prolactin function.

Area of Science:

  • Biochemistry
  • Reproductive Biology
  • Immunology

Background:

  • Prolactin is a key hormone in reproduction and lactation.
  • Glycosylation of prolactin can alter its biological activity.
  • Amniotic fluid contains various proteins, including hormones and immunoglobulins.

Purpose of the Study:

  • To investigate the molecular form of glycosylated prolactin in amniotic fluid.
  • To identify proteins covalently bound to glycosylated prolactin.
  • To elucidate the nature of the linkage between glycosylated prolactin and other proteins.

Main Methods:

  • Western immunoblotting for protein separation and detection.
  • High-performance liquid chromatography (HPLC) for purification.
  • Protein isolation techniques to identify binding partners.

Main Results:

  • Western blots indicated glycosylated prolactin is covalently bound to another protein.
  • Demonstrated that a specific glycosylated prolactin species is linked to immunoglobulin.
  • Identified disulfide bonds as the mediating linkage in amniotic fluid.

Conclusions:

  • A novel form of prolactin exists in amniotic fluid, bound to immunoglobulin.
  • Disulfide bond linkage suggests a specific post-translational modification or interaction.
  • Understanding this interaction is crucial for comprehending prolactin's role in the amniotic environment.

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Matrix Proteoglycans and Glycoproteins01:21

Matrix Proteoglycans and Glycoproteins

Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...